👇
🇺🇸, 2019 deaths 👇
@robinmonotti This study supports the protocol for high-risk patients, take the time to read it. One could argue that no one has died directly from SARS-CoV-2. https://t.co/etbYnw4s00
@firefoxx66 @edwardcholmes @K_G_Andersen @PeterDaszak @trvrb @R_H_Ebright @Pontifex THIS IS A THREAD OF FACTS FOR THE IDIOTIC SNOBBY IGNORANT SCIENTISTS TO READ AND PROVE ME WRONG 👉 DEAL WITH IT ‼️
“The > common detected pathogen in SARS2- patients was rhinovirus (5.93%), whereas in SARS2+ patients the > common co-pathogen were non-SARS2 coronaviridae 🦠 https://t.co/xCCsq4BgED only 13.4% of the 1,204 SARS2+ & 11.4% of the 7,418 SARS2- patie
RT @PBasiukiewicz: Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%)…
RT @PBasiukiewicz: Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%)…
RT @PBasiukiewicz: Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%)…
RT @PBasiukiewicz: Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%)…
RT @PBasiukiewicz: Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%)…
Non-SARS-CoV-2 infection rates were significantly higher in SARS-CoV-2 + (86%) patients than SARS-CoV-2- patients (76%) (p < 0.0001). https://t.co/hrAONjhd59 @mikolaj_kam
Sometimes I need an abstract painting with esoteric meaning. Sometimes I need hard facts - a.k.a. science. Dr. Massey's published work (and research) on Covid: #Biotech #Covid #Vikor https://t.co/sdBDLdrfJe
RT @FrontMicrobiol: New Research: Respiratory Microbial Co-infection With SARS-CoV-2 https://t.co/5O5jl6QGXE #microbiology
New Research: Respiratory Microbial Co-infection With SARS-CoV-2 https://t.co/5O5jl6QGXE #microbiology